Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

about

Organotropism: new insights into molecular mechanisms of breast cancer metastasis.Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease

P2860

Q55353906-9A3A5629-B519-42EB-9814-4E2ACE261CD1 Q56395598-D5970366-EF87-41EC-ABD5-F6AA5D28081E

P2860

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

Item

http://www.wikidata.org/entity/Q41548165

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

@en

type

Item

label

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

@en

prefLabel

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

@en

P1476

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis

@en

P2093

Hyun-Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Junhee Park

http://www.w3.org/2001/XMLSchema#string

Ki Rim Kim

http://www.w3.org/2001/XMLSchema#string

Kwang-Kyun Park

http://www.w3.org/2001/XMLSchema#string

Seung Hwa Son

http://www.w3.org/2001/XMLSchema#string

P2860

Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2

Biology of bone metastases.

Cancer and the chemokine network

Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis

15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss

Osteoclast differentiation and activation

Metastasis to bone: causes, consequences and therapeutic opportunities

Transforming growth factor-beta in osteolytic breast cancer bone metastases.

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

P2888

s41598-017-09040-4

P304

9610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-09040-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Won-Yoon Chung

Sun Kyoung Lee

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28851919

http://www.w3.org/2001/XMLSchema#string

P932

5575024

http://www.w3.org/2001/XMLSchema#string

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

about

P2860

P2860

Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932